Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. - PubMed - NCBI

N Engl J Med. 2015 Oct 22;373(17):1627-39. doi: 10.1056/NEJMoa1507643. Epub 2015 Sep 27. Clinical Trial, Phase III; Comparative Study; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't